Home
Polyplus now part of Sartorius

Polyplus now part of Sar... Market Share Analysis for February 2026

At Polyplus, our innovative plasmid engineering technology e-Zyvec enables assembly of ready-to-use plasmids in a single and controlled reaction from a library of DNA bricks.

Science and Education > Biology

Domainpolyplus-sartorius.com

Year Founded--

Employees51 - 200

Annual Revenue--

Polyplus now part of Sartorius

Polyplus now part of Sartorius (including company regionals)

polyplus-sartorius.com

See more website traffic and engagement information

Total visits to Polyplus now part of Sartorius's top domains

Understand Polyplus now part of Sartorius market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

polyplus-sartorius.com10.1K

See more with Sales Intelligence

Avg. visit duration in Polyplus now part of Sartorius's top domains

Analyze Polyplus now part of Sartorius engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

polyplus-sartorius.com00:00:37

See more with Sales Intelligence

Avg. pageviews on Polyplus now part of Sartorius's top domains

See how Polyplus now part of Sartorius keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

polyplus-sartorius.com1.66

See more with Sales Intelligence

Polyplus now part of Sartorius top competitors by domain

Top similar sites in February 2026, ranked by their affinity

vectorbuilder.comCompany NameVectorBuilderEmployees501 - 1000HQUnited States, California, Santa ClaraAnnual revenue$50M - $75MTotal visits152.6KScience and Education > Biology

Top technologies used by Polyplus now part of Sartorius

These are the website technologies, by industry, used by Polyplus now part of Sartorius top domains

Conversion & Analytics (6)

Google Analytics

Widget (3)

reCAPTCHA

Content Management System (2)

WordPress

Marketing (2)

Google Marketing Platform

More Technologies

6

See all

News & Signals from Polyplus now part of Sartorius

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPolyplus Inc launches innovative plasmid for AAV vector production.Polyplus launches innovative plasmid for AAV vector production, strengthening its position in biologic and cell & gene therapy solutions.

NewsPolyplus Inc is developing CGT efficiency standards.Polyplus, part of Sartorius, agreed to collaborate with MarkHerz, a Korean cell and gene therapy (CGT) CDMO, to develop new CGT efficiency standards focused on decreasing cost and increasing quality per dose of a therapeutic product.

NewsSartorius acquired Polyplus Inc for $2.6B on Apr 1st '23.Further, it is worth highlighting that in April 2023, Sartorius announced the acquisition of Polyplus for total amount of USD 2.6 billion with an aim to strengthen its portfolio for transfection reagents, DNA/RNA delivery reagents for the production of viral vectors.